Prostate cancer 4+5 equals 9 is advanced

The Gleason score for prostate cancer is not simply equivalent to advanced cancer. Doctors also consider factors such as age, health status, tumor size, etc. to assess cancer severity and determine treatment options. Prostate cancer 4 + 5 is not equal to 9. This scoring system cannot be simply equivalent to advanced cancer. The Gleason score for prostate cancer is a commonly used method to assess the histological characteristics of prostate cancer. It is obtained by observing the morphology and structure of tumor cells in prostate cancer tissue, classifying them into major and minor grades, and adding the two together. Gleason scores are usually between 2 and 10, with higher scores indicating higher malignancy. Gleason scores are an important reference in the diagnosis and treatment of prostate cancer, but they are not the only determinant. The doctor also considers factors such as the patient's age, health status, tumor size, location, PSA levels, etc. to assess the severity of the cancer and determine treatment options. In addition, prostate cancer staging is not only determined by Gleason score, but also requires more detailed imaging and pathological evaluation to determine whether the tumor has spread to surrounding tissues or distant organs. Therefore, for prostate cancer patients, comprehensive evaluation and diagnosis should be carried out, including Gleason score, staging, etc., in order to develop personalized treatment plan. At the same time, patients and family members should actively communicate with their doctors to understand the disease and treatment options and make informed decisions. It is important to note that prostate cancer usually has no obvious symptoms in its early stages, so regular prostate cancer screening is important for early detection and treatment. For older men or men with a family history of prostate cancer, more attention should be paid to prostate health and timely screening.